Pieris teams up with AstraZeneca on respiratory drug development

Small Boston-based Pieris Pharmaceuticals is joining forces with AstraZeneca to speed development of its protein platform for application in respiratory diseases, announcing Wednesday a broad collaboration with the British pharma.

Spotlight

Spotlight

Related News